Last Updated: June 27, 2026

Patent: 9,096,666

✉ Email this page to a colleague

Summary for Patent: 9,096,666

Title:	Purified antibody composition
Abstract:	The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
Inventor(s):	Wan; Min M (Worcester, MA), Avgerinos; George (Sudbury, MA), Zarbis-Papastoitsis; Gregory (Watertown, MA)
Assignee:	AbbVie Biotechnology Ltd (Hamilton, BM)
Application Number:	14/550,809
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,096,666
Patent Claims:	see list of patent claims

Details for Patent 9,096,666

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	December 31, 2002	⤷ Start Trial	2034-11-21
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	February 21, 2008	⤷ Start Trial	2034-11-21
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	April 24, 2013	⤷ Start Trial	2034-11-21
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	September 23, 2014	⤷ Start Trial	2034-11-21
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	November 23, 2015	⤷ Start Trial	2034-11-21
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	March 09, 2016	⤷ Start Trial	2034-11-21
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	October 17, 2016	⤷ Start Trial	2034-11-21
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 9,096,666

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Australia	2007235484	⤷ Start Trial
Brazil	PI0709726	⤷ Start Trial
Canada	2647029	⤷ Start Trial
Canada	2911000	⤷ Start Trial
China	101454025	⤷ Start Trial
China	102391358	⤷ Start Trial
China	102887955	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.